The S100A9-specific in vivo imaging presented here allows the assessment of changes in the natural TME non-invasively and longitudinally over time, reflecting immediate and divergent therapy effects, even before the size or morphology of the tumor are responding. Here, S100A9 is linked to neoplasm.